{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T17:39:02Z","timestamp":1774978742344,"version":"3.50.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T00:00:00Z","timestamp":1498176000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"EGIS Pharmaceuticals PLC"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1007\/s12325-017-0572-1","type":"journal-article","created":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T04:49:49Z","timestamp":1498193389000},"page":"1753-1763","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["The Antihypertensive Efficacy of the Triple Fixed Combination of Perindopril, Indapamide, and Amlodipine: The Results of the PETRA Study"],"prefix":"10.1007","volume":"34","author":[{"given":"Gy\u00f6rgy","family":"\u00c1brah\u00e1m","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7203-0423","authenticated-orcid":false,"given":"Csaba Andr\u00e1s","family":"D\u00e9zsi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,6,23]]},"reference":[{"issue":"4","key":"572_CR1","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.ccl.2010.07.001","volume":"28","author":"M Singh","year":"2010","unstructured":"Singh M, Mensah GA, Bakris G. Pathogenesis and clinical physiology of hypertension. Cardiol Clin. 2010;28(4):545\u201359.","journal-title":"Cardiol Clin"},{"issue":"5A","key":"572_CR2","doi-asserted-by":"crossref","first-page":"30S","DOI":"10.1016\/j.amjmed.2003.10.018","volume":"116","author":"GL Bakris","year":"2004","unstructured":"Bakris GL. The importance of blood pressure control in the patient with diabetes. Am J Med. 2004;116(5A):30S\u20138S.","journal-title":"Am J Med"},{"key":"572_CR3","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0140-6736(05)67185-1","volume":"366","author":"B Dahl\u00f6f","year":"2005","unstructured":"Dahl\u00f6f B, Sever PS, Poulter NR, et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicenter randomised controlled trial. Lancet. 2005;366:895\u2013906.","journal-title":"Lancet"},{"key":"572_CR4","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1056\/NEJMoa0806182","volume":"359","author":"K Jamerson","year":"2008","unstructured":"Jamerson K, Weber MA, Bakris GL, et al. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med. 2008;359:2417\u201328.","journal-title":"N Engl J Med"},{"key":"572_CR5","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/j.1751-7176.2010.00360.x","volume":"12","author":"AH Gradman","year":"2010","unstructured":"Gradman AH. Rationale for triple-combination therapy for management of high blood pressure. J Clin Hypertens (Greenwich). 2010;12:869\u201378.","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"572_CR6","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1093\/eurheartj\/eht151","volume":"34","author":"G Mancia","year":"2013","unstructured":"Mancia G, Robert Fagard R, Narkiewicz K, et al. 2013 ESH\/ESC Guidelines for themanagement of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013;34:2159\u2013219.","journal-title":"Eur Heart J"},{"key":"572_CR7","unstructured":"NICE. Clinical guideline 127. Hypertension in adults: diagnois and management. \n                        http:\/\/www.nice.org.uk\/guidance\/CG127\/NICEGuidance\n                        \n                    . Accessed Nov 2016."},{"key":"572_CR8","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S0140-6736(03)14286-9","volume":"362","author":"K Fox","year":"2003","unstructured":"Fox K, et al. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). Lancet. 2003;362:782\u20138.","journal-title":"Lancet"},{"issue":"3","key":"572_CR9","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s40256-013-0058-8","volume":"14","author":"CA D\u00e9zsi","year":"2014","unstructured":"D\u00e9zsi CA. Differences in the clinical effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a critical review of the evidence. Am J Cardiovasc Drugs. 2014;14(3):167\u201373.","journal-title":"Am J Cardiovasc Drugs"},{"key":"572_CR10","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(01)06178-5","volume":"358","author":"PROGRESS Collaborative Group","year":"2001","unstructured":"PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet. 2001;358:1033\u201341.","journal-title":"Lancet"},{"key":"572_CR11","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0140-6736(07)61303-8","volume":"370","author":"ADVANCE Collaborative Group","year":"2007","unstructured":"ADVANCE Collaborative Group. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet. 2007;370:829\u201340.","journal-title":"Lancet"},{"key":"572_CR12","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1056\/NEJMoa0801369","volume":"358","author":"NS Beckett","year":"2008","unstructured":"Beckett NS, Peters R, et al. (HYVET): Treatment of hypertension in patients 80\u00a0years of age or older. N Engl J Med. 2008;358:1887\u201398.","journal-title":"N Engl J Med"},{"key":"572_CR13","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1001\/jama.292.18.2217","volume":"292","author":"S Nissen","year":"2004","unstructured":"Nissen S, et al. Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial. JAMA. 2004;292:2217\u201326.","journal-title":"JAMA"},{"issue":"23","key":"572_CR14","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1001\/jama.288.23.2981","volume":"288","author":"ALLHAT","year":"2002","unstructured":"ALLHAT. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002;288(23):2981\u201397.","journal-title":"JAMA"},{"key":"572_CR15","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0140-6736(05)67185-1","volume":"366","author":"B Dahl\u00f6f","year":"2005","unstructured":"Dahl\u00f6f B, Sever PS, Poulter NR, et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet. 2005;366:895\u2013906.","journal-title":"Lancet"},{"key":"572_CR16","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/jhh.2009.76","volume":"24","author":"M Thoenes","year":"2010","unstructured":"Thoenes M, Neuberger HR, Volpe M, et al. Antihypertensive drug therapy and blood pressure control in men and women: an international perspective. J Hum Hypertens. 2010;24:336\u201344.","journal-title":"J Hum Hypertens"},{"key":"572_CR17","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1097\/00004872-200305000-00011","volume":"21","author":"H Lithell","year":"2003","unstructured":"Lithell H, Hansson L, Skoog I, et al. The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial. J Hypertens. 2003;21:875\u201386.","journal-title":"J Hypertens"},{"key":"572_CR18","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s40261-014-0223-0","volume":"34","author":"D P\u00e1ll","year":"2014","unstructured":"P\u00e1ll D, Sz\u00e1nt\u00f3 I, Szab\u00f3 Z. Triple combination therapy in hypertension: the antihypertensive efficacy of treatment with perindopril, amlodipine, and indapamide SR. Clin Drug Investig. 2014;34:701\u20138.","journal-title":"Clin Drug Investig"},{"issue":"2","key":"572_CR19","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s40256-014-0067-2","volume":"14","author":"K T\u00f3th","year":"2014","unstructured":"T\u00f3th K. Antihypertensive efficacy of triple combination perindopril\/indapamide plus amlodipine in high-risk hypertensives: results of the PIANIST Study (Perindopril-Indapamide plus AmlodipiNe in high rISk hyperTensive patients). Am J Cardiovasc Drugs. 2014;14(2):137\u201345.","journal-title":"Am J Cardiovasc Drugs"},{"issue":"2","key":"572_CR20","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1161\/HYPERTENSIONAHA.113.02252","volume":"63","author":"J Chalmers","year":"2014","unstructured":"Chalmers J, Arima H, Woodward M, Mancia G, et al. Effects of combination of perindopril, indapamide, and calcium channel blockers in patients with type 2 diabetes mellitus: results from the Action In Diabetes and Vascular Disease: Preterax and Diamicron Controlled Evaluation (ADVANCE) trial. Hypertension. 2014;63(2):259\u201364.","journal-title":"Hypertension"},{"key":"572_CR21","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1001\/archinte.165.10.1147","volume":"165","author":"RH Chapman","year":"2005","unstructured":"Chapman RH, Benner JS, Petrilla AA, et al. Predictors of adherence with antihypertensive and lipid-lowering therapy. Arch Intern Med. 2005;165:1147\u201352.","journal-title":"Arch Intern Med"},{"key":"572_CR22","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.amjmed.2006.08.033","volume":"120","author":"S Bangalore","year":"2007","unstructured":"Bangalore S, Kamalakkannan G, Parkar S, Messerli FH, et al. Fixed-dose combinations improve medication compliance: a meta-analysis. Am J Med. 2007;120:713\u20139.","journal-title":"Am J Med"},{"key":"572_CR23","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2147\/CEOR.S15619","volume":"3","author":"LD Esposti","year":"2011","unstructured":"Esposti LD, Saragoni S, Benemei S, et al. Adherence to antihypertensive medications and health outcomes among newly treated hypertensive patients. Clin Econ Outcomes Res. 2011;3:47\u201354.","journal-title":"Clin Econ Outcomes Res"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12325-017-0572-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-017-0572-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-017-0572-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,9,4]],"date-time":"2017-09-04T01:37:24Z","timestamp":1504489044000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12325-017-0572-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6,23]]},"references-count":23,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["572"],"URL":"https:\/\/doi.org\/10.1007\/s12325-017-0572-1","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6,23]]}}}